LPL Financial’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13,515
| Closed | -$93.8K | – | 5294 |
|
2024
Q3 | $93.8K | Sell |
13,515
-2,809
| -17% | -$19.5K | ﹤0.01% | 4801 |
|
2024
Q2 | $80K | Buy |
16,324
+267
| +2% | +$1.31K | ﹤0.01% | 4674 |
|
2024
Q1 | $93.1K | Sell |
16,057
-707
| -4% | -$4.1K | ﹤0.01% | 4616 |
|
2023
Q4 | $110K | Sell |
16,764
-2,829
| -14% | -$18.5K | ﹤0.01% | 4469 |
|
2023
Q3 | $94.4K | Buy |
19,593
+4,062
| +26% | +$19.6K | ﹤0.01% | 4376 |
|
2023
Q2 | $79.2K | Sell |
15,531
-1,250
| -7% | -$6.38K | ﹤0.01% | 4311 |
|
2023
Q1 | $92.3K | Buy |
16,781
+6,431
| +62% | +$35.4K | ﹤0.01% | 4190 |
|
2022
Q4 | $47.5K | Sell |
10,350
-350
| -3% | -$1.61K | ﹤0.01% | 4242 |
|
2022
Q3 | $67K | Buy |
10,700
+200
| +2% | +$1.25K | ﹤0.01% | 4155 |
|
2022
Q2 | $47K | Sell |
10,500
-50
| -0.5% | -$224 | ﹤0.01% | 4215 |
|
2022
Q1 | $53K | Buy |
+10,550
| New | +$53K | ﹤0.01% | 4028 |
|
2021
Q3 | – | Sell |
-13,250
| Closed | -$170K | – | 4400 |
|
2021
Q2 | $170K | Buy |
+13,250
| New | +$170K | ﹤0.01% | 3929 |
|
2020
Q2 | – | Sell |
-875
| Closed | -$3K | – | 3481 |
|
2020
Q1 | $3K | Buy |
+875
| New | +$3K | ﹤0.01% | 3192 |
|